How many patents does
Glaxosmithkline Intellectual Property Development have?
patents
2,669
families
281
granted
384
applications
2,285
US
347
WO
248
EP
243
CN
149
JP
143
KR
125
GB
96
RoW
1,318
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Glaxosmithkline Intellectual Property Development
Top ten assignees appearing on patents
2009 - 2018
Glaxosmithkline Intellectual Property Development
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| oxazole substituted indazoles as pi3-kinase inhibitors | 79 | 2009 |
| heterocyclic amides as kinase inhibitors | 68 | 2013 |
| indolecarbonitriles as selective androgen receptor modulators | 53 | 2012 |
| naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists | 51 | 2013 |
| prodrugs of amino quinazoline kinase inhibitor | 48 | 2012 |
| pyridine derivatives as rearranged during transfection (ret) kinase inhibitors | 45 | 2013 |
| novel pharmaceutical composition | 40 | 2010 |
| cyclopropylamines as lsd1 inhibitors | 35 | 2011 |
| 2,3-dihydroimidazol[1,2-c]pyrimidin-5(1h)-one based lipoprotein-associated phospholipase… 🛈 | 33 | 2013 |
| 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use … 🛈 | 32 | 2013 |